Anushi Bulumulle

Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade

David J. Pinato, Takahiro Kaneko, Anwaar Saeed et al. · Cancers · 2020 · 74 citations · Full text

Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice

David J. Pinato, Thomas U. Marron, Pallavi S. Mishra‐Kalyani et al. · European Journal of Cancer · 2021 · 62 citations

Hepatology, Landmark Clinical Trials, Medicine +12

Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study

Petros Fessas, Ahmed O. Kaseb, Yinghong Wang et al. · Journal for ImmunoTherapy of Cancer · 2020 · 59 citations · Full text

Pathology, Post-registration Experience, Oncology +17

Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma

Petros Fessas, Muntaha Naeem, Matthias Pinter et al. · Liver Cancer · 2021 · 59 citations · Full text

Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy

David J. Pinato, Ahmed O. Kaseb, Yinghong Wang et al. · Journal for ImmunoTherapy of Cancer · 2020 · 35 citations · Full text